461 related articles for article (PubMed ID: 35552983)
1. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
Lau M; Young PM; Traini D
Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
[TBL] [Abstract][Full Text] [Related]
4. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers.
ElKasabgy NA; Adel IM; Elmeligy MF
AAPS PharmSciTech; 2020 Aug; 21(7):238. PubMed ID: 32827062
[TBL] [Abstract][Full Text] [Related]
6. Dry powder inhalers of antitubercular drugs.
Nainwal N; Sharma Y; Jakhmola V
Tuberculosis (Edinb); 2022 Jul; 135():102228. PubMed ID: 35779497
[TBL] [Abstract][Full Text] [Related]
7. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Cavalli F; Usmani OS; Rogliani P
Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
[No Abstract] [Full Text] [Related]
8. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
[TBL] [Abstract][Full Text] [Related]
9. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
Scichilone N; Benfante A; Bocchino M; Braido F; Paggiaro P; Papi A; Santus P; Sanduzzi A
Pulm Pharmacol Ther; 2015 Apr; 31():63-7. PubMed ID: 25724817
[TBL] [Abstract][Full Text] [Related]
10. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
Aggarwal B; Gogtay J
Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
[TBL] [Abstract][Full Text] [Related]
11. Metered-dose inhalers and dry powder inhalers in aerosol therapy.
Hess DR
Respir Care; 2005 Oct; 50(10):1376-83. PubMed ID: 16185372
[TBL] [Abstract][Full Text] [Related]
12. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study.
Ramadan WH; Sarkis AT
Chron Respir Dis; 2017 Aug; 14(3):309-320. PubMed ID: 28774201
[TBL] [Abstract][Full Text] [Related]
13. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
Pepper AN; Cooke A; Livingston L; Lockey RF
Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
[TBL] [Abstract][Full Text] [Related]
14. The inhalation of drugs: advantages and problems.
Rau JL
Respir Care; 2005 Mar; 50(3):367-82. PubMed ID: 15737247
[TBL] [Abstract][Full Text] [Related]
15. Use of Airway Replicas in Lung Delivery Applications.
Golshahi L; Finlay WH; Wachtel H
J Aerosol Med Pulm Drug Deliv; 2022 Apr; 35(2):61-72. PubMed ID: 35262408
[TBL] [Abstract][Full Text] [Related]
16. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.
Lavorini F; Mannini C; Chellini E; Fontana GA
Drugs Aging; 2016 Jul; 33(7):461-73. PubMed ID: 27216613
[TBL] [Abstract][Full Text] [Related]
17. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
18. Aerosol Delivery Devices for Obstructive Lung Diseases.
Pleasants RA; Hess DR
Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
[TBL] [Abstract][Full Text] [Related]
19. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary drug delivery: novel pharmaceutical technologies breathe new life into the lungs.
Nanjwade BK; Adichwal SA; Gaikwad KR; Parikh KA; Manvi FV
PDA J Pharm Sci Technol; 2011; 65(5):513-34. PubMed ID: 22293840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]